Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
Press Releases
Endo, Inc.  
December 9, 2024

Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India

20,000-square-foot site increases Endo's sterile injectable production capacityThis marks the site's first U.S. FDA approvalEndo is investing and innovating in its Injectable Solutions business

logo salamanca press

Salamanca Press

Local & Social